Julia Talsma, Content Channel Director
Julia Talsma is lead editor for Drug Topics magazine.
PCSK9 inhibitor approved for lowering cholesterol
FDA has approved evolocumab (Repatha, Amgen) injection, a human monoclonal antibody that inhibits proprotein convertase subtilisin/kexin type 9 (PCSK9), for some patients who are not able to adequately control low-density lipoprotein (LDL) cholesterol with current therapies.
A host of new generics launch in 2015
A look at some of the year's launches from key manufacturers.
Safeguarding the U.S. drug supply
Safeguarding the U.S. drug supply
The product-tracing deadline has been extended to November 1. Other requirements are on schedule. Here's what you have to do, and when you have to do it.
CVS reports strong second quarter with specialty pharmacy growth
CVS Health reported a strong second quarter in 2015 with overall net revenue up 7.4% to $37.2 million, compared to the same period last year.
Two cases of rare brain infection seen with MS drug
Two patients taking the multiple sclerosis drug fingolimod (Gilenya) developed progressive multifocal leukoencephalopathy (PML), a rare and serious brain infection, FDA reported.
Prescribing, dispensing errors seen with Brintellix, Brilinta
FDA issued a drug safety warning that there have been 50 reports of medication errors because of confusion between the antidepressant Brintellix (vortioxetine) and the antiplatelet agent Brilinta (ticagrelor).
Nursing home oversight gets a boost with CMS proposal
At the White House Conference on Aging, the Centers for Medicare and Medicaid (CMS) proposed new rules to improve the care of approximately 1.5 million elderly who reside in more than 15,000 long-term care (LTC) facilities nationwide. If finalized, a pharmacist will review a resident's chart at least every 6 months.
FDA warns of early MI, stroke risk with non-aspirin NSAIDs
MI and stroke risk can rise just weeks after NSAID use commences. Labels will be updated to reflect this.
ASHP calls for adequate pharmacist representation on state boards of pharmacy
Last month, the American Society of Health-System Pharmacists (ASHP) approved a policy that calls for adequate pharmacist representation on state boards of pharmacy by pharmacists from various practice settings, including hospitals, health systems, clinics, and nontraditional settings, to ensure proper oversight to protect public health.
Hospital discharge service by pharmacists cuts COPD readmission rates
Patients hospitalized for chronic obstructive pulmonary disease (COPD) are at high risk for 30- and 60-day readmissions. In 2008, the mean 60-day admission rate following an emergency department visit of COPD patients was 18% and the mean readmission rate was more than 30%.